Researchers have found that Dulaglutide, a commonly used drug for Type 2 diabetes, can be effective against cardiovascular and kidney diseases too. A clinical trial that followed more than 9,900 persons in 24 countries found that the drug reduced cardiovascular events and kidney problems in middle-aged and older people.

